End-point | HPV-vaccinated women (33 792 person years) | Non-HPV-vaccinated women (174 340 person years) | ||
n | Rate (95% CI) | n | Rate (95% CI) | |
Cervical cancer | 0 | – | 14 | 8.0 (4.8 to 13.6) |
All HPV-positive cancers† | 0 | – | 17 | 9.8 (6.1 to 15.7) |
Breast cancer | 3 | 8.9 (2.9 to 28) | 27 | 15.5 (10.6 to 23) |
Thyroid cancer | 2 | 5.9 (1.5 to 24) | 16 | 9.2 (5.6 to 15.0) |
Melanoma | 8 | 23.8 (11.8 to 47) | 22 | 12.6 (8.3 to 19.2) |
*For corresponding age-aligned sub-cohorts, up to 11 years of passive follow-up was by the population-based Finnish Cancer Registry.
†14 cervical cancers, one vaginal cancer, one vulvar cancer, one tongue cancer.